About: Pexelizumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

Pexelizumab is a drug designed to reduce side effects of coronary artery bypass grafting and angioplasty, among other types of cardiac surgery. It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the complement system.

Property	Value
dbo:abstract	Pexelizumab is a drug designed to reduce side effects of coronary artery bypass grafting and angioplasty, among other types of cardiac surgery. It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the complement system. (en)
dbo:casNumber	219685-93-5
dbo:fdaUniiCode	CHZ6OLQ3UU
dbo:kegg	D10023
dbo:wikiPageID	9134216 (xsd:integer)
dbo:wikiPageLength	3219 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1032291091 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cardiac_surgery dbr:Coronary_artery_bypass_grafting dbr:Pharmaceutical_drug dbc:Abandoned_drugs dbr:Complement_system dbr:Monoclonal_antibody dbr:Angioplasty dbr:Complement_component_5 dbc:Monoclonal_antibodies dbr:Single_chain_variable_fragment
dbp:atcPrefix	none (en)
dbp:casNumber	219685 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:kegg	D10023 (en)
dbp:legalStatus	investigational (en)
dbp:mabType	scFv (en)
dbp:source	zu/o (en)
dbp:target	dbr:Complement_component_5
dbp:type	mab (en)
dbp:unii	CHZ6OLQ3UU (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	464199643 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Keggcite dbt:Monoclonals_for_immune_system dbt:Immunosuppressants dbt:Monoclonal-antibody-stub
dcterms:subject	dbc:Abandoned_drugs dbc:Monoclonal_antibodies
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 umbel-rc:DrugProduct
rdfs:comment	Pexelizumab is a drug designed to reduce side effects of coronary artery bypass grafting and angioplasty, among other types of cardiac surgery. It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the complement system. (en)
rdfs:label	Pexelizumab (en)
owl:sameAs	freebase:Pexelizumab yago-res:Pexelizumab wikidata:Pexelizumab https://global.dbpedia.org/id/4tWKe dbr:Pexelizumab
prov:wasDerivedFrom	wikipedia-en:Pexelizumab?oldid=1032291091&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Pexelizumab
is dbo:wikiPageWikiLink of	dbr:List_of_therapeutic_monoclonal_antibodies dbr:Single-chain_variable_fragment dbr:List_of_drugs:_Pb–Pe
is foaf:primaryTopic of	wikipedia-en:Pexelizumab